Hepatitis C virus NS3-4A serine protease inhibitors: SAR of [formula omitted] moiety with improved potency
| Autor: | Arasappan, A., Njoroge, F.G., Chan, T.-Y., Bennett, F., Bogen, S.L., Chen, K., Gu, H., Hong, L., Jao, E., Liu, Y.-T., Lovey, R.G., Parekh, T., Pike, R.E., Pinto, P., Santhanam, B., Venkatraman, S., Vaccaro, H., Wang, H., Yang, X., Zhu, Z., Mckittrick, B., Saksena, A.K., Girijavallabhan, V., Pichardo, J., Butkiewicz, N., Ingram, R., Malcolm, B., Prongay, A., Yao, N., Marten, B., Madison, V., Kemp, S., Levy, O., Lim-Wilby, M., Tamura, S., Ganguly, A.K. |
|---|---|
| Zdroj: | In Bioorganic & Medicinal Chemistry Letters 2005 15(19):4180-4184 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect